Guddur

Guddur

Auto-generated profile, based on publicly available information

Guddur

Rajiv Gandhi University of Health Sciences, Bengaluru 560 041, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2020 in Letters in Drug Design & Discovery
Verified
Journal Article
Closed access
PDF file
MSMahendra Gowdru Srinivas
Mahendra Gowdru Srinivas
PPPrabitha Prabhakaran
Prabitha Prabhakaran
SMSubhankar Probhat Mandal
Subhankar Probhat Mandal
YSYuvaraj Sivamani
Yuvaraj Sivamani
PGPranesh Guddur
Pranesh Guddur
PRPrashantha B R
Prashantha B R
Background: Thiazolidinediones and its bioisostere, namely, rhodanines have become ubiquitous class of heterocyclic compounds in drug design and discovery. In the present study, as part of molecular design, a series of novel glitazones that are feasible to synthesize in our laboratory were subjected to docking studies against PPAR-γ receptor for their selection. Methods and Results: As part of the synthesis of selected twelve glitazones, the core moiety, pyridine incorporated rhodanine was synthesized via dithiocarbamate. Later, a series of glitazones were prepared via Knovenageal condensation. In silico docking studies were performed against PPARγ protein (2PRG). The titled compounds were investigated for their cytotoxic activity against 3T3-L1 cells to identify the cytotoxicity window of the glitazones. Further, within the cytotoxicity window, glitazones were screened for glucose uptake activity against L6 cells to assess their possible antidiabetic activity. Conclusion: Based on the glucose uptake results, structure activity relationships are drawn for the title compounds.